BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7769877)

  • 1. [Clinical trials with drugs: the influence of the authorization process].
    Carcas AJ; Serrano MA; Avendaño C; Galende I; Tristán C; García-Alonso F
    Med Clin (Barc); 1995 May; 104(18):683-8. PubMed ID: 7769877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The quality of clinical trials published in Spain: an evaluation by an analysis of 3 journals during the 1985-1991 period].
    Soto J; Galende I; Sacristán JA
    Med Clin (Barc); 1994 Feb; 102(7):241-5. PubMed ID: 8170209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of legal regulations on the quality of clinical trials carried out in Spain].
    García López FJ
    Med Clin (Barc); 1993 May; 100(20):770-7. PubMed ID: 8321053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trials published in Revista Española de Anestesiología y Reanimación: characteristics and quality of design].
    García-Alamino JM; Parera A; Ollé G; Bonfill X
    Rev Esp Anestesiol Reanim; 2007; 54(6):333-9. PubMed ID: 17695943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodology standards associated with quality reporting in clinical studies in pediatric surgery journals.
    Thakur A; Wang EC; Chiu TT; Chen W; Ko CY; Chang JT; Atkinson JB; Fonkalsrud EW; Grosfeld JL
    J Pediatr Surg; 2001 Aug; 36(8):1160-4. PubMed ID: 11479847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacy Department standard procedures for clinical trial development].
    Pérez Peiró C; Porta Oltra B; Cholvi Llovell M; Jiménez Torres NV
    Farm Hosp; 2004; 28(1):36-47. PubMed ID: 15012177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [International diffusion of clinical trials carried out in Spain. An analysis based on their publication in scientific journals].
    Baños JE; Bosch F; Bigorra J; Guardiola E
    Med Clin (Barc); 1994 Apr; 102(12):441-5. PubMed ID: 8207992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differences in the quality of Spanish clinical trials published in international periodicals and of the ones presented in general medicine periodicals with wide readership].
    Delgado Rodríguez M; Ruiz-Canela M; de Irala-Estévez J; Llorca Díaz J; Martínez-González MA
    Rev Clin Esp; 2001 Aug; 201(8):437-43. PubMed ID: 11599154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
    Ekimoto H
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials in Israel. Criteria for approval.
    Nir I
    Isr J Med Sci; 1983 May; 19(5):445-8. PubMed ID: 6862851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An analysis of patient information sheets for obtaining informed consent in clinical trials].
    Ordovás Baines JP; López Briz E; Urbieta Sanz E; Torregrosa Sánchez R; Jiménez Torres NV
    Med Clin (Barc); 1999 Jan; 112(3):90-4. PubMed ID: 10074615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre trials review process by research ethics committees in Spain: where do they stand before implementing the new European regulation?
    Dal-Ré R; Ortega R; Morejón E
    J Med Ethics; 2005 Jun; 31(6):344-50. PubMed ID: 15923484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    Dilts DM; Sandler AB
    J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEC-net: the development of the European register of clinical trials on medicines for children.
    Santoro E; Rossi V; Pandolfini C; Bonati M
    Clin Trials; 2006; 3(4):366-75. PubMed ID: 17060211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is proper methodology associated with the use of a clinically relevant outcome measure? The case of randomized clinical trials on medical treatment of open-angle glaucoma.
    Rossetti L; Marchetti I; Orzalesi N; Scorpiglione N; Liberati A
    Online J Curr Clin Trials; 1993 Nov; Doc No 100():[6512 words; 199 paragraphs]. PubMed ID: 8305993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological quality and reporting of ethical requirements in phase III cancer trials.
    Tuech JJ; Pessaux P; Moutel G; Thoma V; Schraub S; Herve C
    J Med Ethics; 2005 May; 31(5):251-5. PubMed ID: 15863678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality control in clinical trials].
    Fukushima M
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):172-82. PubMed ID: 8611045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.